Ligand Pharmaceuticals Inc. (Nasdaq: LGND) is revising upward its previous revenue and net income guidance for the fourth quarter and full year 2013 as a result of higher-than-expected sales of Captisol material.
San Diego-based Sequenom Inc. (Nasdaq: SQNM) announced Wednesday that Laboratoire Cerba has launched its validated noninvasive prenatal test (NIPT) to health care providers and their patients in France, Belgium, Luxembourg and portions of the Middle East and Africa.
Shares of Ambit Biosciences tumbled Wednesday after the company said it won't file for accelerated approval of its leukemia drug quizartinib, and will run a late-stage clinical trial instead.
San Diego’s OmniBiome Therapeutics Inc., a biotech company focused on preventing preterm labor, has launched.
Medicines Co. has acquired a San Diego-based privately held drugmaker that has developed several potential treatments for serious infections in a deal that could be worth more than $400 million.
Dec. 4, 2013, 5:00 p.m. -- In local news, the countywide vacancy rate for rentals decreased this fall, and the second Plug and Play San Diego pitch competition lived up to the success of its predecessor.
June 20, 2013 -- George Chamberlin speaks with Dr. Elizabeth Hernandez, vice president of social services for Neighborhood House Association, about how sequestration has affected NHA's budget and what services will be impacted by the Affordable Care Act.
George Chamberlin discusses Health Care Reform and the major changes that will be affecting businesses, families and individuals with Raul Quiñones, a Health Care Reform Expert from Health Savings Associates Insurance Services.